Abstract
Proteomic investigations are of primary importance for discovery-driven biomarker studies. In fact, for understanding the biochemical and physiological differences between tumor and normal cells/tissues, and for using these differences in compound design, synthesis, and targeting, it is important to investigate protein profiles related to physiological and pathological conditions, and to describe the effect of bioactive compounds. Today, different proteomic methodologies are available for clinical proteomic applications. In this chapter, the main steps of traditional two-dimensional gel electrophoresis (2DE) and innovative multidimensional protein identification (MudPIT) are described, which are useful for BNCT investigations. In particular, some results concerning the possibility of characterizing proteins interacting with 10boron compounds and shotgun proteomic analysis of tumor tissues for biomarker discovery using a mass spectrometry-based approach are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BSH:
-
Sodium mercaptoundecahydro-closo-dodecaborate
- BPA:
-
L-para-boronophenylalanine
- PVDF:
-
Polyvinylidene fluoride transfer membranes
- MudPIT:
-
Multidimensional protein identification technology
- LC-MS/MS:
-
Liquid tandem mass spectrometry
- IPG:
-
Immobilized pH gradient
- SDS-PAGE:
-
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
References
Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz O, Sanchez JC, Yan JX, Gooley AA, Hughes G, Humphrey-Smith I (1996) From proteins to proteomes – large-scale protein identification by 2-dimensional electrophoresis and amino acid analysis. Biotechnology 14:61–65
Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL, Humphery-Smith I (1995) Progress with gene-product mapping of the Mollicutes: mycoplasma genitalium. Electrophoresis 7:1090–1094
Mauri PL, Petretto A, Cuccabita D, Basilico F, Di Silvestre D, Levreri I, Melioli G (2008) Fractionation techniques improve the proteomic analysis of human serum. Curr Pharm Anal 4:69–77
Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, Hertenstein B, Mischak H, Weissinger EM (2004) Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104:340–349
Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48:1296–1304
Florens L, Washburn MP (2006) Proteomic analysis by multidimensional protein identification technology. Methods Mol Biol 328:159–175
Sorio C, Mauri PL, Pederzoli P, Scarpa A (2006) Non-invasive cancer detection: strategies for the identification of novel cancer markers. IUBMB Life 58(4):193–198
Anderson NL, Anderson NG (2002) The human plasma proteome – history, character, and diagnostic prospects. Mol Cell Proteomics 1(11):845–867
Wolters DA, Washburn MP, Yates JR 3rd (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73:5683–5690
Washburn MP, Wolters D, Yates JR 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242–247
Wu CC, Yates JR 3rd (2003) The application of mass spectrometry to membrane proteomics. Nat Biotechnol 21:262–267
Lim H, Eng J, Yates JR 3rd, Tollaksen SL, Giometti CS, Holden JF, Adams MW, Reich CI, Olsen GJ, Hays LG (2003) Identification of 2D-gel proteins: a comparison of MALDI/TOF peptide mass mapping to mu LC-ESI tandem mass spectrometry. J Am Soc Mass Spectrom 14(9):957–970
Liu H, Sadygov RG, Yates JR 3rd (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76:4193–4201
Mauri PL, Dehò G (2008) A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli. Methods Enzymol 447:99–117
Tyers M, Mann M (2003) From genomics to proteomics. Nature 422(6928):193–197
Maurya P, Meleady P, Dowling P, Clynes M (2007) Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 27(3A):1247–1255
Mauri P, Scarpa A, Nascimbeni AC, Benazzi L, Parmagnani E, Mafficini A, Della Peruta M, Bassi C, Miyazaki K, Sorio C (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 19(9):1125–1127
Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R, Brentnall TA (2005) Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 129(4):1187–1197
Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, Kislinger T (2008) Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol Biosyst 4(7):762–773
Salinovich O, Montelaro RC (1986) Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Anal Biochem 156:341–347
Altieri S, Bortolussi S, Bruschi P, Chiari P, Fossati F, Stella S, Prati U, Roveda L, Zonta A, Zonta C, Ferrari C, Clerici A, Nano R, Pinelli T (2008) Neutron autoradiography imaging of selective boron uptake in human metastatic tumours. Appl Radiat Isot 66(12):1850–1855
Mauri PL, Basilico F, Wittig A, Heimans J, Sauerwein W (2006). Pharmacokinetics and metabolites of 10B-contaning compounds in biological fluids. In: Oral presentation. 12th ICNCT, Kagawa, 9 Oct 2006
Mauri PL, Basilico F, Pietta PG, Pasini E, Monti D, Sauerwein W (2003) New approach for the detection of BSH and its metabolites using capillary electrophoresis and electrospray ionization mass spectrometry. J Chromatogr B 788(1):9–16
Doi A, Kawabata S, Iida K, Yokoyama K, Kajimoto Y, Kuroiwa T, Shirakawa T, Kirihata M, Kasaoka S, Maruyama K, Kumada H, Sakurai Y, Masunaga S, Ono K, Miyatake S (2008) Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. J Neurooncol 87(3):287–294
Hale JE, Butler JP, Gelfanova V, You JS, Knierman MD (2004) A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis. Anal Biochem 333(1):174–181
Winston RL, Fitzgerald MC (1998) Concentration and desalting of protein samples for mass spectrometry analysis. Anal Biochem 262(1):83–85
Regonesi ME, Del Favero M, Basilico F, Briani F, Benazzi L, Tortora P, Mauri P, Dehò G (2006) Analysis of the Escherichia coli RNA degradosome composition by a proteomic approach. Biochimie 88(2):151–161
Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR 3rd (1999) Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17(7):676–682
Righetti PG, Boschetti E (2007) Sherlock Holmes and the proteome – a detective story. FEBS J 274(4):897–905
Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF 3rd, Liotta L (2003) Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol 532:59–68
Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y, Petricoin EF 3rd, Emmert-Buck MR (2003) Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics 3(4):413–421
Veenstra TD, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS (2005) Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 4(4):409–418
Liu W, Brock A, Chen S, Chen S, Schultz PG (2007) Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nat Methods 4(3):239–244
Acknowledgements
The authors are grateful to Dr. A. Roveri and Dr. S. Altieri for the PHGPx reaction with BSH and neutron autoradiography, respectively.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mauri, P.L., Basilico, F. (2012). Proteomic Investigations for Boron Neutron Capture Therapy. In: Sauerwein, W., Wittig, A., Moss, R., Nakagawa, Y. (eds) Neutron Capture Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31334-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-31334-9_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31333-2
Online ISBN: 978-3-642-31334-9
eBook Packages: MedicineMedicine (R0)